FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Somerset Therapeutics Haloperidol decanoate Injection 50mg/mL Recall

Haloperidol decanoate Injection 50mg/mL, packaged in a) 1 mL Single-Dose Vials (NDC 700…

SOMERSET THERAPEUTICS LLC · Somerset, NJ

Risk level
Class II
Reported by FDA
May 29, 2024
Recall ID
D-0506-2024
Check your lot numberHow we source this data

Summary

Somerset Therapeutics recalled Haloperidol decanoate Injection 50mg/mL starting Apr 24, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0506-2024 on May 29, 2024. Reason: Presence of Foreign Substance: This oil based product may contain trace amounts of water for injection (WFI). Status: Ongoing.

Why it was recalled

Presence of Foreign Substance: This oil based product may contain trace amounts of water for injection (WFI).

Product description

Haloperidol decanoate Injection 50mg/mL, packaged in a) 1 mL Single-Dose Vials (NDC 70069-381-01) and b) 10 1mL Single-Dose Vials (NDC 70069-381-10), Rx only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India.

Lot numbers, UPCs & expiration codes

Lot #: a) A230412A, Exp. Date 07/2025; b)A230412B, Exp. Date 07/2025

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0506-2024
Classification
Class II
Status
Ongoing
Recall initiated
Apr 24, 2024
FDA report date
May 29, 2024
Quantity
5,578 units
Recall type
Voluntary: Firm initiated
Recalling firm
SOMERSET THERAPEUTICS LLC

Original FDA data

Every field from FDA enforcement report D-0506-2024, exactly as published.

Show all FDA fields
City
Somerset
State
NJ
Status
Ongoing
Country
United States
Event ID
94452
Address
300 Franklin Square Dr
Code information
Lot #: a) A230412A, Exp. Date 07/2025; b)A230412B, Exp. Date 07/2025
Postal code
08873-4187
Report date
May 29, 2024
Product type
Drugs
Recall number
D-0506-2024
Classification
Class II
Recalling firm
SOMERSET THERAPEUTICS LLC
Product quantity
5,578 units
Reason for recall
Presence of Foreign Substance: This oil based product may contain trace amounts of water for injection (WFI).
Voluntary / mandated
Voluntary: Firm initiated
Product description
Haloperidol decanoate Injection 50mg/mL, packaged in a) 1 mL Single-Dose Vials (NDC 70069-381-01) and b) 10 1mL Single-Dose Vials (NDC 70069-381-10), Rx only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India.
Distribution pattern
Nationwide within the United States
Recall initiation date
Apr 24, 2024
Initial firm notification
Letter
Center classification date
May 21, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0506-2024, published May 29, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls